Vigil Neurosciences logo

Vigil Neurosciences

Vigil Neurosciences is a microglia-based Therapeutics for Neurodegenerative Diseases.

1

Funding Rounds

$90.0m

Money raised

Overview

Vigil Neurosciences is a microglia-based Therapeutics for Neurodegenerative Diseases.

Funding series

Funding Series Analysis

The company Vigil Neurosciences has raised a total of $90m in funding over 1 rounds.

Key Insights:

  • Vigil Neurosciences Series B round, August 18, 2021: $90m
Vigil Neurosciences logo
Vigil Neurosciences Series B round, August 18, 2021 $90m